{"id":50274,"date":"2022-10-31T15:02:24","date_gmt":"2022-10-31T14:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/"},"modified":"2022-10-31T15:02:24","modified_gmt":"2022-10-31T14:02:24","slug":"u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/","title":{"rendered":"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5661976\/u-s-real-world-evidence-solutions-market-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=66l9bp&amp;utm_campaign=1769295+-+U.S.+Real-World+Evidence+Solutions+Market+Report+2022%3A+Growing+Adoption+of+RWE+in+Drug+Development+and+Commercialization+to+Reshape+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;U.S. Real-World Evidence Solutions Market by Component, Application, End User &#8211; Forecast to 2029&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe U.S. RWE solutions market is expected to grow at a CAGR of 13.1% from 2022 to 2029 to reach $2.22 billion by 2029\n<\/p>\n<p>\nGrowing incidence of chronic &amp; infectious diseases, delays in drug development and the subsequent increase in development costs, rising focus towards personalized healthcare, a shift from volume to value-based care, and rapidly growing big data in healthcare are the key factors driving steady growth in the U.S. RWE solutions market.\n<\/p>\n<p>\nFurther, significant opportunities for existing market players and new entrants are provided by rising focus on end-to-end RWE services, and rising adoption of wearable devices and AI in RWE.\n<\/p>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nDrivers\n<\/p>\n<ul>\n<li>\nGrowing Burden of Chronic and Infectious Diseases\n<\/li>\n<li>\nRising Focus Towards Personalized Healthcare\n<\/li>\n<li>\nDelays in Drug Development and the Subsequent Increase in Development Costs\n<\/li>\n<li>\nShift Towards Value-Based Care\n<\/li>\n<li>\nRapidly Growing Big Data in Healthcare\n<\/li>\n<\/ul>\n<p>\nRestraints\n<\/p>\n<ul>\n<li>\nReluctance to Rely on Real-World Studies\n<\/li>\n<\/ul>\n<p>\nOpportunities\n<\/p>\n<ul>\n<li>\nRising Focus on End-to-End RWE Services\n<\/li>\n<li>\nRising Adoption of Wearable Devices and Artificial Intelligence in RWE\n<\/li>\n<\/ul>\n<p>\nChallenges\n<\/p>\n<ul>\n<li>\nLack of Standardized Methodologies to Develop RWE\n<\/li>\n<\/ul>\n<p>\nKey Market Trends\n<\/p>\n<ul>\n<li>\nGrowing Adoption of RWE in Drug Development and Commercialization\n<\/li>\n<li>\nRising Number of Consolidations\n<\/li>\n<li>\nImproved Patient Outcomes and Value Creation from Real-World Evidence\u00a0\n<\/li>\n<\/ul>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<p>\n<strong>U.S. RWE Solutions Market, by Component<\/strong>\n<\/p>\n<ul>\n<li>\nDatasets\n<\/li>\n<li>\nDisparate Datasets\n<\/li>\n<li>\nEMR\/EHR\/Clinical Data\n<\/li>\n<li>\nClaims &amp; Billing Data\n<\/li>\n<li>\nPharmacy Data\n<\/li>\n<li>\nProduct\/Disease Registries Data\n<\/li>\n<li>\nOther Disparate Datasets\n<\/li>\n<li>\nIntegrated Datasets\n<\/li>\n<li>\nConsulting and Analytics\n<\/li>\n<\/ul>\n<p>\n<strong>U.S. RWE Solutions Market, by Application<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Access &amp; Reimbursement\/Coverage Decisions\n<\/li>\n<li>\nDrug Development &amp; Approvals\n<\/li>\n<li>\nOncology\n<\/li>\n<li>\nNeurology\n<\/li>\n<li>\nImmunology\n<\/li>\n<li>\nCardiovascular Diseases\n<\/li>\n<li>\nOther Therapeutic Areas\n<\/li>\n<li>\nPost Market Surveillance\n<\/li>\n<li>\nMedical Device Development &amp; Approvals\n<\/li>\n<li>\nClinical and Regulatory Decision-Making\n<\/li>\n<\/ul>\n<p>\n<strong>U.S. RWE Solutions Market, by End User<\/strong>\n<\/p>\n<ul>\n<li>\nPharmaceutical, Biotechnology, and Medical Device Companies\n<\/li>\n<li>\nHealthcare Payers\n<\/li>\n<li>\nHealthcare Providers\n<\/li>\n<li>\nOther End Users\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Introduction<\/strong>\n<\/p>\n<p>\n<strong>2. Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>3. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4. Market Insights<\/strong>\n<\/p>\n<p>\n<strong>5. Regulatory Analysis &#8211; U.S. Real-World Evidence (RWE) Solutions Market<\/strong>\n<\/p>\n<p>\n<strong>6. Pricing Models (EMR\/Genomic\/Integrated Datasets)<\/strong>\n<\/p>\n<p>\n<strong>7. U.S. Real-World Evidence Solutions Market, by Component<\/strong>\n<\/p>\n<p>\n<strong>8. U.S. Real-World Evidence Solutions Market, by Application<\/strong>\n<\/p>\n<p>\n<strong>9. U.S. Real-World Evidence Solutions Market, by End User<\/strong>\n<\/p>\n<p>\n<strong>10. Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>11. Company Profiles (Business Overview, Financial Overview, Solution Portfolio, Strategic Developments)<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAnthem Inc. (U.S.)\n<\/li>\n<li>\nClinigen Group plc (U.K.)\n<\/li>\n<li>\nCognizant Technology Solutions Corporation (U.S.)\n<\/li>\n<li>\nIBM Corporation (U.S.)\n<\/li>\n<li>\nICON plc (Ireland)\n<\/li>\n<li>\nIQVIA HOLDINGS INC. (U.S.)\n<\/li>\n<li>\nOracle Corporation (U.S.)\n<\/li>\n<li>\nPAREXEL International Corporation (U.S.)\n<\/li>\n<li>\nPerkinElmer Inc. (U.S.)\n<\/li>\n<li>\nPPD Inc. (U.S.)\n<\/li>\n<li>\nSAS Institute Inc. (U.S.)\n<\/li>\n<li>\nUnitedHealth Group Incorporated (U.S.)\n<\/li>\n<li>\nFlatiron Health Inc. (U.S.)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5661976\/u-s-real-world-evidence-solutions-market-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=66l9bp&amp;utm_campaign=1769295+-+U.S.+Real-World+Evidence+Solutions+Market+Report+2022%3A+Growing+Adoption+of+RWE+in+Drug+Development+and+Commercialization+to+Reshape+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/wzw62r<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:p&#114;&#101;&#115;&#115;&#64;&#114;&#101;&#115;&#101;&#97;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;&#x63;om\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#114;&#x65;s&#101;&#x61;r&#99;&#x68;&#97;&#x6e;&#x64;&#109;&#x61;&#x72;&#107;&#x65;t&#115;&#x2e;c&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;U.S. Real-World Evidence Solutions Market by Component, Application, End User &#8211; Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The U.S. RWE solutions market is expected to grow at a CAGR of 13.1% from 2022 to 2029 to reach $2.22 billion by 2029 Growing incidence of chronic &amp; infectious diseases, delays &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50274","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;U.S. Real-World Evidence Solutions Market by Component, Application, End User &#8211; Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The U.S. RWE solutions market is expected to grow at a CAGR of 13.1% from 2022 to 2029 to reach $2.22 billion by 2029 Growing incidence of chronic &amp; infectious diseases, delays ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-31T14:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-31T14:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/\"},\"wordCount\":513,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005489\\\/en\\\/1618873\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/\",\"name\":\"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005489\\\/en\\\/1618873\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-31T14:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005489\\\/en\\\/1618873\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005489\\\/en\\\/1618873\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;U.S. Real-World Evidence Solutions Market by Component, Application, End User &#8211; Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The U.S. RWE solutions market is expected to grow at a CAGR of 13.1% from 2022 to 2029 to reach $2.22 billion by 2029 Growing incidence of chronic &amp; infectious diseases, delays ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-31T14:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector &#8211; ResearchAndMarkets.com","datePublished":"2022-10-31T14:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/"},"wordCount":513,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/","name":"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg","datePublished":"2022-10-31T14:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221031005489\/en\/1618873\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"U.S. Real-World Evidence Solutions Market Report 2022: Growing Adoption of RWE in Drug Development and Commercialization to Reshape Sector &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50274"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50274\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}